Chicago—Different ropivacaine concentrations in transversus abdominis plane (TAP) block for post-cesarean analgesia yield unpredictably varying analgesic benefits and wide confidence intervals in morbidly obese women, according to a randomized clinical trial. The results have served to add fuel to the fire over the controversy of the block’s efficacy.
“At our institution, morbidly obese parturients do not receive neuraxial morphine for post-cesarean analgesia because of